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A new type of mitollcnic factor ~rot¢in) was purified from the culture supertzatant of n strain or sttepr~¢weuxp.w~tenes by SP-Sephadex C-2S 
column chromatol~raphy, p~parativ¢ imel¢¢tri¢ focusin$ and rcvcr,~d.pha~: hillh.l~:rfomlan~ liquid chromatOllraphy, The purified t'actor, 
showinll marked mitoseni¢ activity in rabbit peripheral blood lymphocyte~. ~av© a single.band staininll for protein on SDS.PAGE, Tile molecular 
weiliht of the purified mitol~nic factor was determined to be 25,370. which was different from tho~ ¢-.,k:alated from reported amino acid ~quenc~ 
deduced from 4 different nueleotid¢ ~qaences of 3 kinds of streptococcal pyro~nic exotoxlns (two SPEAs, SPEB and SPEC), Tile amino acid 
~quence of the N.terminal re$ion of the purified mitolieni¢ factor was determined to be GIn-Thr.GIn.VaI.S~.Asn.AspVaI-VaI-Leu-Asn-AspGly- 
Ala.Scr.L~.Tyr-l,,.¢u-Asn-Glu-Ala-, whicit was aim different from the reported N.tem~inai u:quen~s dedu~d from the 4 different nucleotide 
sequences, These data indicate that this mitogenic factor is distinct from the already d~,tcribed streptocoo:al pyro~¢n[c xotoxins, 
Strepto¢~rrus pyoxtne~. Mito~nic activity: Streptocoo:al pyroleni¢ toxin; SPEA; SPEB: SPEC 
1. INTRODUCTION 
Group A streptococci produce several extracellular 
proteins such as streptolysin O. streptolysin S and 
erythrogenic toxins [1]. Erythrol;enic toxin, or ~trepto- 
coccal pyrog=nic exotoxin (SPE), considered to b¢ a 
pathogenic asent of scarlet fever, is characterized by 
biological activities such as pyrogenicity, mitogenicity. 
enhancement of susceptibility to endotoxin shock. ~up- 
pression ot' IBM and enhancement of IsG production 
[1]. Three serolo[tically distinct streptococcal pyrogenic 
exotoxins, SPEA, SPEB and SPEC have so far been 
reported [2-.4]. and nueleotide sequences of the genes of 
these toxins have been determined [5-8]. While attempt- 
ing to purify the streptococcal pyrogenic exotoxins, we 
found a new type of mitosenic factor differing from 
these three kinds of streptococcal pyrogenic exotoxins 
in its N-terminal amino acid sequence, Here we report 
the purification of this new type of mitogenic factor 
produced by Streptococcus pyogenes and its N-terminal 
amino acid sequence, 
2, MATERIALS AND METHODS 
2,1. Bacterial strain and culture medium 
Strt, pto¢oecus pyoltenex strain NY-5 provided by Dr. T. Nakahara 
(Saitama Colles¢ of Health, Urawa, Japan) was used. Dactcrial cells 
were cultured at 37"C for 24 h with intermittent stirrinB in the medium 
as described by 18arashi etal, [9], which contained 4qt NZ-aminc 
Corre~'pondencc addreq," T, Yutsudo, Shionosi Institute for Medical 
Science. 2.5.1 Mishim:t, Setta, Osaka S66, Japan. 
(Wako Pure Chemical, O~'tka), 0, I S~ >~Lst extract (Difco Lahorato. 
ries, USA). and 0.2ft Illu¢o~. 
2.2, A~uv Df mitogeJ~ic aetivio' 
Mitollenic activity was as~yed a,~ described by Abe ct al, [10]. 
Briefly. ¢¢11s from hcparinized peripheral venou,, blood from a rabbit 
were ~parated from plasma, mixed with an equal volu'n¢ of 1~ 
polyvinyi alcohol in pho,,phate.bufl~red saline, pH ?,O (PDS). and 
incubated at 37°C for 30 rain in a water bath. Tile leukocyte.rich 
fraction was co11¢¢:.--.d. =rid washed 3 time', with PBS. The cells ware 
suspended at a cell density of I x 10"lml in Dull~cco's modified EaBIc 
Medium containing l0 mM N.2.hydroxyethyl.piperazine./~.2.ethane 
sulfonic acid, lO0#$/ml ol'kanamycin a d 20~ inactivated autolo~ous 
or homolo$ou,, ~rum, Then 0.2 ml aliquots of the c¢11 suspension wera 
introduced into well,, or a 96-,a,ell mierotiter plate and cultured for 4 
days in a CO.. incubator, Test matcrial~ were added at the start of 
culture, Con A at a concentration f S/tbtml was u~d us a positive 
control, Seventeen hour,~ before the end of cuhurc, [metlJyh~H].thy - 
midine ()H.TdR, An~er,,Alam.Japan, Tokyo) was added at ~, ¢o,a~:n- 
tration of 9.2S Oqlml, Ceils were harvested on glass fiber filters 
(Printed filter mat A. Pharmacia, Sweden) with a ~11 harvuter Crype 
1295-001. LKB, Sweden) and radioactivity was determined in a liquid 
scintilla:ion spectrometer (Type 1205 i]ctaplate, LKB, Sweden). 
2.3. h'P.Sephadex C.25 cohmm chrontarc~gruphy 
Culture supernatant,, obtained by ccntrifutlation at 10,000 x j~ for 
20 rain were filtered through amembrane filter ('Nihon Millipore Ltd.. 
Tokyo} and diluted 5-fold with distilled water, The/were then mixed 
with SP.Sephad~'x C-25 gel equilibrated with 0,01 M citrate phosphate 
buffer (DH 4,6) and kept overnight at 4'C, Alter adsorption of the 
factor, the SP-Sephadex C-25 gel was collected by filtration, and 
introdu'cod Into a column of S x 30 era. The adsorbed material was 
then ctuted successively with 2,000 ml of 0.01 M citrate phosphate 
buffer (pH 4.6), 1,0O0 nat of 0.02 M citrate pho,~phate buffer (pH 6,?)° 
and 1,0130 ml of 0,01 M citrate phosphate buffer (pH 4,6) contatninil 
I M NaCI, Fractions with mito~cnic activity were collected and con- 
centrated to a small volume by ultra filtration on an AreS:on YM-10 
membrane (Amicon Corporation, Ireland), 
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2.4. Prepcmmv¢ ixo¢l¢¢tric foru~'h~£ 
The eluat¢ from the SP.Sephadcx C-25 column was dialyxed ailainst 
dislillcd w--=tcr and applied to an Ampholin¢ column type 8101 (LKB, 
Sweden). Isoelectric focusing was perform~ at 200 V for 4t¢ h. Alter 
¢lc¢~rophor~is, the material was fractionated and frac|ions with mite- 
=chic activity were collected. 
2.$. J~¢rer:;rd.pl~ux¢ high performance liquM ehrm..lugraph, i" 
The preparation from the preparative isoelcctri¢ focasinB column 
was subjected to rcver,~d-pha~ hillh-pcrforman¢¢ liquid ¢hromato$- 
raphy (HPLC) on a Cosmosil 5C~=-P300 column (4.6 x 150 ram. 
Nacalai Torque, Kyoto) in a Waters HPLC system, model LC.204 
(Water~, Nihon Millipor¢ Ltd,. Tokyo), Material w-.,~ ¢lu|ed with a 
linear IFudicnt of ace|onitorile (20.-80~,. I~,lmin) in 0,05~ tri- 
fluoroa~ctic acid at = flow rate of I mffmin, and the absorbanccs of 
the eluate at 214 nm and 280 nm were monitored, 
2.6. Chrmn, t~fuc~lnX ~llmm du',m,t,~r,phy 
The cluate from th~ SP-Sephadex C-25 column v,~s dialy',~cd alWinst 
25 mM imidazol¢-HCI bul'fcr (pH 7,4) and applied to a column (! x 
40 era) of 30 ml of poiybulTcr cx¢ltanlier PBE94 (Pharmacia. Sweden) 
that hud been ccluilibratcd with 25 mM imidazole.HCI buffer (pH 7,4) 
and clu|cd with polybuffer 74 (pH 4.0) to obtain u i~nldient ol'pH ?,O 
to 4.0, Fractions with mitolienic ;tetivity were collected. 
2,?, Pulyacr3"hmlide ~el rle¢lrupharesix 
Sodium dodccyl sulfulc (SDS).polyacrylamid¢ slab gel electropho- 
r~is was carried out as described by Laemmii [1 l] in 12% ucrylan~id¢ 
$¢1. 
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FiB. I, Preparative isoclcctric CocusinB of the rnimsenic factor, 
Preparative i~=lectric Cocusinil w~s pcrl'ormed as d~crilx~d in the text, 
After el~trophoresis, fractions o1' 2,8 ml were collected, Samples ~:r¢ 
diluted lO0.fold with PUS and tcited for mitog=nic uctivity. A.~a).~ 
were doac in triplicate. A nel~tive control (PUS) and positive control 
(Con A) i/ave about 90-140 and I h000-13,000 ¢pm. r~poctivcly. The 
bar with arrowheads hows the fractions collected ('or further purl flea. 
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FiB. 2, Reversed.phase HPLC of the, mitogenie f~ctor. The absorban~ at 214 nm (A=.) and 280 nm (A=w) of the ¢luat;: w~ro monitor¢~ 
simultaneously, The fractions .,hewn by a bar with arrowheads wen. collated and subjected to SDS-PAGE as described in the text. Insert: the 
result of the SDS.polyacrylamide gel electropitor~is, Lane S, purified factor; lane M, molcular weight marke~, Numbers on the risht margin 
repre~nt the molecular weight of the markers. 
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Fig, 3. Ion.spray mass si~'etram of the puritied mitogeni¢ fiLctor, The initog.enie fitctor isolated by revcrsed.ph:ts¢ HPLC was directly subjected 
to ion-spray ma~ sp==trometry a,~ described in tltc text. From retch s~. value of the multiply ehariled ioa sisn:ds (IM +nH]"'). the molecular weisht 
of tile mito~enic I'actor was ~tlculated to be .~5,370 ~ 3. 
2,8. ~mhm .¢M ¢m.p.siti.. am/svquenre cm.ll'sL~" 
The amino acid compost ion of the parilied to,~in was determined 
in an L.8500 amino acid an;,I.),',~er (Hitachi Ltd, Tokyo) ~d'ter hydroly. 
sis of samples in 5.7 N hydrochloric acid at I IO'C Ibr 48 h in evacu. 
ated sealed tu~s. For aa;,ly..is of the amino acid sequence, the purified 
factor was dissolved in 3 vols. ora solution of 37% acctonitrilc, 63~ 
acetic acid, ;tad one volume of 2S% aqueous trifluoroitceti¢ :told was 
added, The i'nixtu~e wa~ then examialgd {11 ;in autol~lated g;ts.phas¢ 
amino acid ~qucn~r  (Model PSQ.I. Shiraadzu Corporation, Kyoto). 
2.9. Detvrmi.atiot~ , l)tOlvhj 
Protein content was determined witi~ a protein ;;ssay kit (llio.Rad 
Laboratories, USA), The protein content of the purified fuctor w;is 
calculated from the valu=~ determined by amino acid composition 
analysis, 
2, lO, M¢.sttre~ttettt of iuJt.sprto' mtt,v.v spectr. 
Ion-spray mass spectra were measured on a triple quadruple mass 
spectrometer (SCIEX APIIt, Canada) equipped with ;i standard ;tt. 
mospherie pressure ionization source. The purified factor isolated by 
HPLC was dissolved in 0,1¢~ aqueous trifluoro.'tcefic acid containing 
S0~ acetonitrilo and infused into the ion source ~1 a flow rate of 20 
/JI/min. Details of the procedure were described previously [12], 
3, RESULTS AND DISCUSSION 
The culture sup=mutant prepared as d~scribgd in sec- 
tion 2 was chromatographed on an SP-Sephadex C25 
column. Materials with mitogc,fic activity were eluted 
with 0,02 M eitr.'tte phosphate buffer (pH 6,'1) and with 
0,01 M citrate phosphate buffer (pH 4,6) containing 1 
M NaCI. The former eluate was found to contain SPEA 
by further chromatography on a chrom;LtoTocusing col- 
umn and amino acid sequence analysis (data not 
shown). The latter eluate was collected and applied to 
a preparative isoelectric focusing column. As shown in 
Fig. 1, material with mitogenic activity was eluted be- 
tween pH 7.6 and 8,4, The fractions with activity were 
collected and subjected to reversed.phase HPLC. As 
shown in Fig. 2, this material gave :t sharp peak of 
protein with several minor protein peaks, The sharp 
peak indic~'tted by a b; : with arrowheads howed 
marked mitogenic activity, whereas the other peaks did 
not, On SDS-PAGE (insert in Fig. 2), the purified hctor 
gave a single band staining tbr protein with a molecular 
weight of 27.000-28.000, Thus, this fr.'tction was col. 
leered as the purified factor. The optimal dose (EDso) 
of the purified mitogenic factor for rabbit peripl~eral 
blood lymphocytes was about 300 ng/ml, In contrast. 
the optimal dose of SPEA for a mi'.oggnic effect on 
C57BL/6 spleen cells is reported to be 3 to lO/ag/ml [13], 
Although we did not examine the mitogenic activity of 
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Table i 
Comparison of amino acid compositions of the purifi=d mitolicnic 
factor and strei~o¢o~al pyrojcnic ¢xotoxins produ=d by $~rrpto¢¢~, 
¢#~# l~)'nj~¢n¢ .," 
Molecular ralio {'~) 
MF SPEA-W SPEA-J SPEB SPEC 
Asp/A~ 16,1 14,0 i2,3 13.0 17,3 
Thr 8,0 6,3 7,3 3.6 S.7 
Set 4,8 6,8 7.7 8.7 ?,7 
Glu/Gln 0.8 [2,7 10.9 9.1 8,2 
GIy 10.4 4,1 4.t 11.9 5.3 
Ala 8.4 !,8 i.4 7. I 2,4 
Val 6.9 6.3 6.4 T.5 3.4 
M~,t 0.0 1.3 1.4 1.6 1.4 
lie 33 5,9 6.t$ 4.3 i0,1 
Lea t(.4 9,0 ~.6 5.S 6.2 
'ryr ~.8 17 7.a ~,9 8.3 
Phe 2,1 4,1 S.O 4.0 5.3 
Ly~ 4,1~ 10,0 10,0 5,5 10,1 
His 1,6 2,7 2.3 2.1~ !9 
Arl/. 5,4 1.3 2.7 2.S 3.4 
Pro 3.7 4. l 3.6 4.7 1,9 
Trp ND 0,5 0,5 1.6 0.0 
Cys ND 1,4 l,tl 0,4 0.$ 
The amino acid composition o1" the mito=enic factor purified in this 
study (MF)  was analysed as d¢seribed in Ihe text. The amino acid 
compost|ions of SPEA. SPEB. and SPEC were calculated from re- 
ported, amino acid =qucn¢~ deduo=d from the nucl=otid¢ sequences 
of the r~p~:ti~ toxins [5=8], SPEA-W and SPEA.J were both re- 
ported as Mrepto¢o~al cxotoxin type A by Weeks and Fcrrctti iS] and 
Johnson el al, [6]. P~p~ctivety. ND. not d~tcrmined, 
the purified mitogcnic factor on mouse spleen ¢¢11s, w= 
suppose that this mitogenic factor has potential bio[og- 
ical activ':y on mammalian lymphocytes. 
Ion-spray mass sp~trometry of the purified factor 
showed that its molecular weight was 25,370 +_ 3 (Fig. 
3). This value is similar to, but not the same as, those 
of SPEA reported by Weeks and Ferretti [5] (M, = 
2L787), SPEA reported by Johnson et al. [6] (Mr = 
25,805), SPEB (M, = 27.588) [7] and SPEC (M, - 
24.z~4) [s]. 
The amino acid composition of the purified factor 
shown in Table I is quite different from those of SPEAs. 
SPEB and SPEC. The sequen¢~ of the first 21 N-termi- 
nal amino acids of the purified factor was determined 
to be GIn-Thr-Gln-Val-Ser-Asn-Asp-VaI.VaI.Lcu.Asn. 
Asp-Gly-Ala-Scr-Lys-Tyr-Lcu-Asn-Glu.Ata-, This se- 
quence is -Iso ditTerent from those of SPEAs,.SPEB atv, l
SPEC (Table 11): neither the N.terminal s~quen¢~ nor 
the sequences of other regions of these already reported 
toxins were identical with the N-terminal sequence of 
the new mito~enic factor. A computer search of data 
bases also showed th.'=t his amino acid ~quenc¢ of this 
mito~enic factor differs from those of known proteins. 
From these results we conclude that the purifi¢d factor 
is a novel mite@air factor produc¢d by Strept¢~coccu~ 
pyogene~'. 
Recently pyrogenic cxotoxins from Strcptuco¢'cus 
pyo~en¢# and certain enterotoxins from Staph)'lococcus 
aureu.s" were reported to comprise a family ofsul~ranti- 
gens [13-15], defined as bifunctional molecules binding 
to NIHC class II structures and activating T cells ex- 
pressing appropriate V beta segmcnt~ of the T cell re- 
ceptor [ [ 6-19]. Further studies to characterize the novel 
mitogenlc factor as a superantigen are now in progress. 
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